Search | IOVS | ARVO Journals

Showing 1 – 20 of 47

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Histatin Stimulates Proliferation in Human Primary Corneal Endothelial Cells

Ramkumar Srinivasagan; Patrick Hughes; James Burke; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4143.

ARVO Annual Meeting Abstract June 2024

Optimization of Next-Generation α-Crystallin Chaperones (αCC) for the Treatment of Dysfunctional Lens Syndrome

Patrick Hughes; James A Burke; Rozemarijn S Verhoeven; Ricardo Cruz; Dell Larned; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5031.

ARVO Annual Meeting Abstract June 2023

Intravitreal α-Crystallin Chaperone Reverses Lens Opalescence in Non-Human Primates with Spontaneous Cataracts

James A Burke; Patrick Hughes; Rozemarijn S Verhoeven; Dell Larned; Sanjay R Kedhar; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2466.

ARVO Annual Meeting Abstract June 2023

Histatin-1 Decreases Corneal Endothelial Cell Death in Ex-Vivo Human Corneas

Onkar Sawant; Jessica Ludwig; Madison Castellanos; Dixie-Lee Shurland; Matt Chang; Ricardo Cruz; Patrick Hughes; James A Burke; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):617.

ARVO Annual Meeting Abstract June 2023

Next-Generation α-Crystallin Chaperones for the Treatment of Dysfunctional Lens Syndrome.

Patrick Hughes; James A Burke; Rozemarijn S Verhoeven; Dell Larned; Ricardo Cruz; Rhett M Schiffman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1224.

ARVO Annual Meeting Abstract June 2022

Histatin Improves Corneal Wound Healing in a Rabbit Model of Surgical Keratectomy

James Burke; Rozemarijn S Verhoeven; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1120.

ARVO Annual Meeting Abstract June 2022

Nonclinical Pharmacokinetics and Pharmacodynamics of Brimochol, a Combination Product for the Treatment of Presbyopia

Rozemarijn S Verhoeven; James Burke; Rhett Schiffman

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1819 – F0435.

ARVO Annual Meeting Abstract June 2021

A Minipump Continuous Drug Infusion Dog Model System to Identify Candidate Drugs and Drug Delivery Rates for Intracameral IOP-lowering Implants

Jie Shen; Michael R Robinson; James Burke; Tim T Lam; Mayssa Attar

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2753.

ARVO Annual Meeting Abstract June 2020

Early structural and functional changes in a non-human primate model of glaucoma

Lakshmi Rajagopalan; Corine Ghosn; James A Burke; Michael Engles

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):274.

ARVO Annual Meeting Abstract June 2020

Tests That Differentiate Early AMD From Age Matched Control Patients.

William H Ridder; Caren Oquindo; Pat Yoshinaga; George Comer; Rima Khankan; Michael Engles; James A Burke

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3004.

ARVO Annual Meeting Abstract July 2019

Ultra-widefield imaging of the retinal vasculature in mild cognitive impairment and Alzheimer’s disease: A pilot study

Emma Jean Roberta Pead; Dilraj S Grewal; Stephen P Yoon; Bryce Polascik; Atalie Thompson; James R Burke; Cynthia Dunn; Emmanuel Trucco; Tom MacGillivray; Sharon Fekrat

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6106.

ARVO Annual Meeting Abstract July 2019

Deep learning algorithm for diagnosis of Alzheimer’s disease using multimodal retinal imaging

Clayton Ellis Wisely; Dong Wang; Ricardo Henao; Dilraj S Grewal; Stephen Paul Yoon; Bryce Polascik; Atalie C. Thompson; James R Burke; Lawrence Carin; Sharon Fekrat

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1461.

Articles January 2019

Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost

PDF

Susan S. Lee; Alexandra Almazan; Sherri Decker; Yan Zhong; Alazar N. Ghebremeskel; Patrick Hughes; Michael R. Robinson; James A. Burke; Robert N. Weinreb
TAGS: bimatoprost, intraocular pressure, pharmacokinetics
Trans. Vis. Sci. Tech.. 2019; 8(1):15. https://doi.org/10.1167/tvst.8.1.15

Retina December 2018

Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability

PDF

Gerard A. Rodrigues; Matthew Mason; Lori-Ann Christie; Candice Hansen; Lisa M. Hernandez; James Burke; Keith A. Luhrs; Thomas C. Hohman
TAGS: angiogenesis, anti-vascular endothelial growth factor therapy, ranibizumab, vascular endothelial growth factor a, affinity, bevacizumab, oryctolagus cuniculus, vascular permeability, aflibercept
Invest. Ophthalmol. Vis. Sci.. 2018; 59(15):5836-5846. https://doi.org/10.1167/iovs.18-25307

ARVO Annual Meeting Abstract July 2018

Comparison of Retinal Microvasculature and Neurodegenerative Changes among Alzheimer’s disease, Mild Cognitive Impairment, and Controls

Stephen Paul Yoon; Dilraj Singh Grewal; Bryce W Polascik; Cynthia Dunn; Kim Johnson; James Burke; Sharon Fekrat

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2818.

ARVO Annual Meeting Abstract July 2018

In Vitro and In Vivo Characterization of Abicipar Pegol, an anti-VEGF DARPin® Therapeutic

Gerry A Rodrigues; Matthew Mason; Lori-Ann Christie; Candice Hansen; James A Burke; Keith Luhrs; Thomas C Hohman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):233.

ARVO Annual Meeting Abstract July 2018

Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) Enhances Spatial Sweep Visual Evoked Potential (sVEP) in a Non-human Primate Model of Chronic Glaucoma

James A Burke; Kai-Ming Zhang; Werhner Orilla; Corine Ghosn; Larry A Wheeler

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1246.

ARVO Annual Meeting Abstract July 2018

fMRI shows Functional Recovery by Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) in a Rabbit Model of Retinal Ganglion Cell (RGC) Degeneration

Corine Ghosn; James A Burke

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6127.

ARVO Annual Meeting Abstract July 2018

In Vivo Angiographic Study of Rabbit Aqueous Outflow following Ab Interno Gelatin Stent Implantation

Susan S Lee; Saumya Nagar; Lakshmi Rajagopalan; Werhner Orilla; Karl G Csaky; Alex Huang; Alexandra Almazan; James A Burke; Michael R Robinson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1653.

ARVO Annual Meeting Abstract July 2018

Visualization of conjunctival lymphatic vessels in normotensive rabbits

Lakshmi Rajagopalan; Saumya Nagar; Werhner Orilla; Karl G Csaky; Alexandra Almazan; James A Burke; Michael R Robinson; Susan S Lee

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1654.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Histatin Stimulates Proliferation in Human Primary Corneal Endothelial Cells

Optimization of Next-Generation α-Crystallin Chaperones (αCC) for the Treatment of Dysfunctional Lens Syndrome

Intravitreal α-Crystallin Chaperone Reverses Lens Opalescence in Non-Human Primates with Spontaneous Cataracts

Histatin-1 Decreases Corneal Endothelial Cell Death in Ex-Vivo Human Corneas

Next-Generation α-Crystallin Chaperones for the Treatment of Dysfunctional Lens Syndrome.

Histatin Improves Corneal Wound Healing in a Rabbit Model of Surgical Keratectomy

Nonclinical Pharmacokinetics and Pharmacodynamics of Brimochol, a Combination Product for the Treatment of Presbyopia

A Minipump Continuous Drug Infusion Dog Model System to Identify Candidate Drugs and Drug Delivery Rates for Intracameral IOP-lowering Implants

Early structural and functional changes in a non-human primate model of glaucoma

Tests That Differentiate Early AMD From Age Matched Control Patients.

Ultra-widefield imaging of the retinal vasculature in mild cognitive impairment and Alzheimer’s disease: A pilot study

Deep learning algorithm for diagnosis of Alzheimer’s disease using multimodal retinal imaging

Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost

Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability

Comparison of Retinal Microvasculature and Neurodegenerative Changes among Alzheimer’s disease, Mild Cognitive Impairment, and Controls

In Vitro and In Vivo Characterization of Abicipar Pegol, an anti-VEGF DARPin® Therapeutic

Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) Enhances Spatial Sweep Visual Evoked Potential (sVEP) in a Non-human Primate Model of Chronic Glaucoma

fMRI shows Functional Recovery by Intravitreal Brimonidine Drug Delivery System (Brimo DDS Generation 1) in a Rabbit Model of Retinal Ganglion Cell (RGC) Degeneration

In Vivo Angiographic Study of Rabbit Aqueous Outflow following Ab Interno Gelatin Stent Implantation

Visualization of conjunctival lymphatic vessels in normotensive rabbits

To View More...

You must be signed into an individual account to use this feature.